Reproductive hormones and hypothalamic-pituitary-ovarian axis in female patients with homozygous β-thalassemia major

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 4, 2010, Pages 259-266

  Safarinejad, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

; thalassemia major; Female; Fertility; Hormones

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DEFEROXAMINE; ESTRADIOL; FERRITIN; FOLLITROPIN; GONADORELIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIPTORELIN; HORMONE; IGFBP3 PROTEIN, HUMAN; SOMATOMEDIN BINDING PROTEIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TRANSFUSION; CHELATION THERAPY; CONTROLLED STUDY; DELAYED PUBERTY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE FERTILITY; FERRITIN BLOOD LEVEL; FOLLITROPIN BLOOD LEVEL; GONADORELIN TEST; GROWTH RATE; GROWTH RETARDATION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENARCHE; MENSTRUATION; OLIGOMENORRHEA; OVARY INSUFFICIENCY; PREVALENCE; PRIMARY AMENORRHEA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECONDARY AMENORRHEA; SHORT STATURE; THALASSEMIA MAJOR; ADOLESCENT; BETA THALASSEMIA; BLOOD; CASE CONTROL STUDY; CHILD; COMPARATIVE STUDY; FERTILITY; HOMOZYGOTE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; MIDDLE AGED; OVARY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PUBERTY;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ESTRADIOL; FEMALE; FERTILITY; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HOMOZYGOTE; HORMONES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; LUTEINIZING HORMONE; MIDDLE AGED; OVARY; PUBERTY; YOUNG ADULT;

EID: 77952775767     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181cf8156     Document Type: Article

References (54)

1. Cooley TB, Lee P. A series of cases of splenomegaly in children with anemia and peculiar changes. Trans Am Pediatr Soc. 1925;37:29-30.
2. Protonotariou AA, Tolis GJ. Reproductive health in female patients with beta-thalassemia major. Ann N Y Acad Sci. 2000;900:119-124.
3. Baker HW, Burger HG, de Kretser DM, et al. A study of the endocrine manifestations of hepatic cirrhosis. QJMed. 1976;45:145-178.
4. Saenger P, Schwartz E, Markenson AL, et al. Depressed serum somatomedin activity in beta-thalassemia. J Pediatr. 1980;96: 214-218.
5. Herington AC, Werther GA, Matthews RN, et al. Studies on the possible mechanism for deficiency of nonsuppressible insulin-like activity in thalassemia major. J Clin Endocrinol Metab. 1981;52:393-398.
6. Gabutti V, Piga A. Results of long-term iron-chelating therapy. Acta Haematol. 1996;95:26-36.
7. Bergeon C, Kovacs K. Pituitary siderosis: a histologic, immunocytologic, and ultrastructural study. Am J Pathol. 1978;9:295-309.
8. Safarinejad MR. Evaluation of semen quality, endocrine profile and hypothalamus-pituitary-testis axis in male patients with homozygous beta-thalassemia major. J Urol. 2008; 179:2327-2332.
9. Raiola G, Galati MC, De Sanctis V, et al. Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab. 2003;2: 259-266.
10. Chatterjee R, Katz M, Cox TF, et al. Prospective study of the hypothalamic-pituitary axis in thalassaemic patients who developed secondary amenorrhoea. Clin Endocrinol. 1993;39: 287-296.
11. Bronspiegel-Weintrob N, Olivieri NF, Tyler B, et al. Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major. N Engl J Med. 1990;323:713-719.
12. George A, Bhaduri A, Sen S, et al. Physical growth parameters in thalassemic children. Indian J Pediatr. 1997;64:861-871.
13. Shehadeh N, Hazani A, Rudolf MC, et al. Neurosecretory dysfunction of growth hormone secretion in thalassemia major. Acta Paediatr Scand. 1990;79:790-795.
14. Jensen CE, Tuck SM, Wonke B. Fertility in beta thalassaemia major: a report of 16 pregnancies, preconceptual evaluation and a review of the literature. Br J Obstet Gynaecol. 1995; 102:625-629.
15. Kumar RM, Rizk DE, Khuranna A. Beta-thalassemia major and successful pregnancy. J Reprod Med. 1997;42:294-298.
16. Seracchioli R, Porcu E, Colombi C, et al. Transfusion-dependent homozygous beta-thalassaemia major: successful twin pregnancy following in-vitro fertilization and tubal embryo transfer. Hum Reprod. 1994;9:1964-1965.
17. Savona-Ventura C, Bonello F. Beta-thalassemia syndromes and pregnancy. Obstet Gynecol Surv. 1994;49:129-137.
18. Fuchs GJ, Tienboon P, Khaled MA, et al. Nutritional support and growth in thalassaemia major. Arch Dis Child. 1997;76: 509-512.
19. Fuchs GJ, Tienboon P, Linpisarn S, et al. Nutritional factors and thalassaemia major. Arch Dis Child. 1996;74:224-227.
20. Low LC. Growth, puberty and endocrine function in beta-thalassaemia major. J Pediatr Endocrinol Metab. 1997;10:175-184.
21. Raiola G, Galati MC, De Sanctis V, et al. Growth failure and bone lesions due to desferrioxamine in thalassaemic patients. J Pediatr Endocrinol Metab. 1998;11:957-960.
22. Tanner JM, Whithehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and the stages of puberty. Arch Dis Child. 1976;51:170-179.
23. Largo RH, Prader A. Pubertal development in Swiss boys. Helv Paediatr Acta. 1983;38:211-228.
24. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and disease complications in thalassemia major. Ann N Y Acad Sci. 1998;850:227-231.
25. Roth C, Pekrun A, Bartz M, et al. Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion. Eur J Pediatr. 1997;156:777-783.
26. de Sanctis V, Angastiniotis M, Eleftheriou A. Pediatric endocrinology reviews. Diabetes, nutrition, metabolism. Bone disease and endocrine complications in thalassaemia [Foreward]. Pediatr Endocrinol Rev. 2008;6(suppl 1):71-72.
27. Vogiatzi MG, Macklin EA, Trachtenberg FL, et al. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America. Br J Haematol. 2009;146:546-556.
28. Gamberini MR, De Sanctis V, Gilli G. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre. Pediatr Endocrinol Rev. 2008;6(suppl 1):158-169.
29. Italian working group on endocrine complications in non-endocrine diseases. Multicentre study on prevalence of endocrine complications in thalassaemia major BM. Clin Endocrinol (Oxf). 1995;42:581-586.
30. Li CK, Luk CW, Ling SC, et al. Morbidity and mortality patterns of thalassaemia major patients in Hong Kong: retrospective study. Hong Kong Med J. 2002;8:255-260.
31. Torres FA, Bonduel M, Sciuccati G, et al. Beta thalassemia major in Argentina. Medicina (B Aires). 2002;62:124-134.
32. Al-Rimawi HS, Jallad MF, Amarin ZO, et al. Hypothalamic-pituitary-gonadal function in adolescent females with beta-thalassemia major. Int J Gynaecol Obstet. 2005;90:44-47.
33. Shamshirsaz AA, Bekheirnia MR, Kamgar M, et al. Metabolic and endocrinologic complication in beta-thalassaemia major: a multicenter study in Tehran. BMC Endocr Disord. 2003;3:1-6.
34. Kwan EY, Lee AC, Li AM, et al. A cross-sectional study of growth, puberty and endocrine function in patients with thalassaemia major in Hong Kong. J Paediatr Child Health. 1995;1:83-87.
35. Hershko C. Iron chelators for thalassaemia. Br J Haematol. 1998;101:399-406.
36. Soliman AT, elZalabany M, Amer M, et al. Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study. J Trop Pediatr. 1999;45:23-30.
37. Daskalakis GJ, Papageorgiou IS, Antsaklis AJ, et al. Pregnancy and homozygous beta thalassaemia major. Br J Obstet Gynaecol. 1998;105: 1028-1032.
38. Qatanani M, Taher A, Koussa S, et al. β-Thalassemia intermedia in Lebanon. Eur J Haematol. 2002;64:237-244.
39. Chern JP, Lin KH. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Pediatr Hematol Oncol. 2002;24:291-293.
40. De Sanctis V, Pintor C, Aliquo MC. Prevalence of endocrine complications in patients with β-thalassemia major: an Italian multicenter study. In: Pinctor C, Muller E, Loche S, et al, eds. Advances in Pediatric Endocrinology. Berlin: Springer; 1992: 127-133.
41. Leger J, Girot R, Crosnier H, et al. GH response to GH-RH in children with thalassemia major before puberty: a possible age related effect. J Clin Endocrinol Metab. 1989;69:453-456.
42. Chrysis DC, Alexandrides TK, Koromantzou E, et al. Novel application of IGF-1 and IGFBP-3 generation tests in the diagnosis of the growth hormone axis disturbances in children with β-thalassemia. Clin Endocrinol. 2001;54:253-259.
43. Low LCK, Postel-Vinay MC, Kwan EYW, et al. Serum growth hormone (GH) binding protein, IGF-1 and IGFBP-3 in patients with a-thalassaemia major and the effect of GH treatment. Clin Endocrinol. 1998;48:641-646.
44. Rodda CP, Reid ED, Johnson S, et al. Short stature in homozygous β-thalassemia is due to disproportionate truncal shortening. Clin Endocrinol. 1995;42:587-592.
45. De Virgiliis S, Congia M, Frau F, et al. Desferrioxamine-induced growth retardation in patients with thalassemia major. J Pediatr. 1988;113:661-669.
46. Fintini D, Brufani C, Cappa M. Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency. Ther Clin Risk Manag. 2009;5:553-559.
47. Spiliotis BE, Alexandrides TK, Karystianos C, et al. The insulin-like growth factor-I (IGF-I) generation test as an indicator of growth hormone status. Hormones (Athens). 2009;8:117-128.
48. Masala A, Meloni T, Gallisai D, et al. Endocrine functioning in multitransfused prepubertal patients with homozygous beta thalassemia. J Clin Enocrinol Metab. 1984;58:667-670.
49. Zervas A, Katopodi A, Protonotariou A, et al. Assessment of thyroid function in two hundred patients with beta-thalassemia major. Thyroid. 2002;12:151-154.
50. Chern JP, Lin KH, Tsai WY, et al. Hypogonadotropic hypogonadism and hematologic phenotype in patients with transfusion-dependent beta-thalassemia. J Pediatr Hematol Oncol. 2003;25:880-884.
51. Shalitin S, Carmi D, Weintrob N, et al. Serum ferritin level as a predictor of impaired growth and puberty in thalasemia major patients. Eur J Haematol. 2005;74:93-100.
52. Karamifar H, Shahriari M, Amirhakimi GH. Linear growth deficiency in beta-thalassemia patients: Is it growth hormone dependent? JMS. 2002;27:47-50.
53. Eshghi P, Alavi S, Ghavami S, et al. Growth impairment in beta-thalassemia major: the role of trace element deficiency and other potential factors. J Pediatr Hematol Oncol. 2007; 29:5-8.
54. Safarinejad MR. Evaluation of endocrine profile, hypothala-mic-pituitary- testis axis and semen quality in multiple sclerosis. J Neuroendocrinol. 2008;20:1368-1375.